Thermalinjuriesareamajorsourceofmorbidityandmortality inthedevelopingworld. [1] Thereareover300,000deathseach yearresultingdirectlyfromfire-relatedburnsalone,withmany moredeathsfromscalds,electricalandotherformsofburns,for which global data are not available. [1] It has been estimated that75%ofalldeathsfollowingthermalinjuriesarerelatedto infection. [2] Optimal management of burns, particularly to prevent and treat infection is therefore essential to improve outcomes. [3] Traditionally, topical antibiotics and antibiotic-impregnated dressings have been used together with systemic antibiotics to preventandtreatinfection. [4] [5] [6] [7] However,thereisapaucityof evidencetosupportthecontinueduseofsystemicantibioticas prophylaxistopreventinfectionfollowingburns. In many centres, including those in the developing world, hospitals have developed local management protocols with systemic antibiotic prophylaxis in patients who have a positive microbiologicalculturefromaburnsiteinanattempttoprevent wound infection and septicaemia. [6, 7] . Despite the large numberofpaediatricburnpatientsindevelopingcountries,itis still unknown if the use of prophylactic systemic antibiotics is effectiveandcost-efficientinpreventinginfectivecomplications. There is a lack of systematic research, standardised treatment protocols,compoundedbylimitedresources. [8] Thisreviewevaluatestheevidenceforefficacyofsystemic[oral (PO)andintravenous(IV)]antibioticprophylaxisindelayingor preventing infection of burns. This is an especially important issueforsevereburnsrequiringoperativewounddebridement, surgicalmanipulationandskingrafting.
METHODS
ArticleswereidentifiedthroughtheMedlinedatabaseusingthe 'Clinical Queries' framework. A broad clinical search strategy was employed using "antibiotics" AND "burns" to receive maximumyield.TheCochraneDatabaseofSystematicReviews, PubMed, and Medline were also hand-searched for relevant studies. Primary outcomes assessed were efficacy of antibiotic prophylaxis, improved clinical outcomes including infection control/prevention, hospital stay, morbidity and mortality. Secondary outcomes included specific infection control/prevention e.g. Group A Steptococcus (GAS) infections andcomparisonofswab/cultureresults. Manuscripts were excluded if: (i) they were not burns-related; (ii)externalbodysurfaceburnwoundswerenotdiscussed;(iii) the outcomes were related to non-clinical endpoints (such as biochemical or pharmacokinetic studies or epidemiological studies or case reports); (iv) antibiotic prophylaxis was mentioned as part of treatment regimen but its role is not further elucidated or quantified; (v) only topical antibiotics were used (the subject of an accompanying separate review) ; (vi)wereexperimentalorinvitrostudies;(vii)containednone or inadequate data for comparison; (viii) the antibiotics used were not related to clinical treatment; (ix) from a special population e.g. ophthalmological burns; (x) the publications were not written in English or (xi) the articles were published before1970. RESULTS Heterogeneityamongstudiesoccurredin5domains:(i)theuse of different antibiotic prophylaxis, durations, doses and modes of administration (oral vs. intravenous); (ii) use of different antibiotic classes and preparations; (iii) non-uniform methods of outcome reporting; (iv) differing prevalence of nosocomial bacteria and background antibiotic resistance at the study site; (v) theseverity ofburnsofpatients studiedand(vi)ageofthe study populations. However studies were not excluded if systemic antibiotic prophylaxis were implemented and discussedwithgoodlevelofevidence. The initial Medline search yielded 636 articles of which 407 wereexcludedaftertitlereview,143wereexcludedonbasisof title and abstract review and 76 excluded based on detailed evaluation.10articleswerefoundsuitableforevaluation. The Cochrane Database of Systematic Reviews was handsearched using the terms "Antibiotic Prophylaxis [MeSH]" AND "Burns[MeSH]".Ofthe10articlesfound,2paediatrictrials [8, 9] and 1 adult trial [10] were included. Medline yielded a further 23 articles after a search for "Antibiotic Prophylaxis" AND "Burns"ofwhich6metinclusioncriteria.Ofthese,3hadalready been found by the Cochrane search and the other 3 paediatric trials were included in this review. [11] [12] [13] PubMed Clinical Queries was interrogated through the MeSH database using "Antibiotic Prophylaxis [MeSH]" AND "Burns [MeSH]". Of 24 articlesidentified,10metinclusioncriteriaofwhich6hadbeen foundintheprevioussearches. The combined search yielded 10 relevant articles which included 4 individual randomised controlled trials (RCTs), 4 prospective cohort studies, 1 prospective and 1 retrospective case-control study. Three contained purely paediatric data, 2 containedpurelyadultdataand4hadmixedpopulationdata. Of the 10 studies which met the search criteria, 3 were performed in developing country hospitals. 2 studies showed continued benefit from routine systemic antibiotic prophylaxis [12, 15] while the other 8 concluded that there is no advantage inthispractice. [8] [9] [10] [11] [13] [14] [16] [17] Specific antibiotics used prophylactically differed considerably betweentrials.Choicesofantibioticsincludedpenicillin [13, 17] , ampicillin [8, 11] ,dicloxacillin [17] ,cloxacillin [8] ,erythromycin [8, 16, 17] , gentamicin [8] , cefazolin [9] , cephalothin [15] , cephradine [17] , piperacillin [14] , tazocin [11] , amikacin [14] , teicoplanin [10] , flucloxacillin [12] , 2nd generation cephalosporins [11] andclarithromycin. [11] Datafromadultstudies A RCT (n=61) in Lagos, Nigeria found that systemic antibiotic prophylaxishadnoeffectincontrollingburnwoundinfectionin patients managed on surgical wards. [8] The prophylaxis of ampicillin, cloxacillin, erythromycin or gentamicin had no significantly beneficial effect on the prevention of colonisation/infectionofburnsnoronthetimetocolonisation orinfection..Furthermore,thefindingsindicatedthatantibiotic prophylaxis may be deleterious, favouring the growth of Pseudomonasaeruginosainburnwounds. [8] Themethodology of this study was sound and relevant to developing countries. However it did not contain paediatric data and did not use standardisedantibioticregimens. An RCT performed in UK on 134 adults compared bacteriological response and clinical outcomes between burns patients who received teicoplanin versus placebo. [10] While there was significant difference in wound culture results, with the antibiotic group significantly having less episodes of perioperative Gram-positive bacteraemia [8 cases (7%) versus 51 cases (46%)] (p < 0.001), clinical outcome was similar in both groups (p=0.7). The study concluded that postoperative recovery was not affected by the prophylactic prevention of Gram-positive bacteraemia. [10] However due to the small sample size and location, it was difficult to determine if the conclusioncanbeextrapolatedtoadevelopingworldhospital. The available adult data do not support the use of antibiotic prophylaxis in burns management. It is unclear if these adult datacanbereadilyextrapolatedtopaediatricpatients. Datafrompaediatricstudies A small RCT (n=23) in Philadelphia, USA investigated the effectiveness of antibiotic prophylaxis at the time of surgical burns wound debridement or grafting. [9] Patients with burns surface area (BSA)<35% received either cefazolin or placebo while patients with BSA >35% received either cefazolin or antibiotics targeted against burn culture results. The study endpointswereclinicaloutcomesandsurveillancecultures.This study reported that prophylactic cefazolin did not influence outcome in patients with either with BSA<35% or BSA >35%. [9] However, this is a relatively old partially-blinded RCT performed more than 10 years ago with a small sample size, and only the abstract was available for consideration. The weightthatcanbegiventotheconclusionsisthereforelimited. A retrospective case-control study (n=77) from Turkey compared 47 patients who received prophylactic antibiotics (tazocin, 2nd generation cephalosporins and clarithromycin) with30patientsreceivednoprophylaxis. [11] Woundinfection rateswereverysimilarinthetwogroupsandofthe8patients with clinical sepsis, all but one of them were from the group who received antibiotic prophylaxis. [11] However, in this retrospectivestudy,thedecisionofprophylacticantibioticsmay have been biased by factors including worse severity of burns, younger age, delay in hospital admission or worse clinical presentation.Thisisawell-written,relevantstudybutstilllacks adequate scientific persuasion, uniformity of antibiotic choice andhasmethodologicalissuesandrelativelypoorpower. Aprospectivecohortstudy(n=50)inBelfast,UKaimedtoassess whetherprophylaxiswithasingledoseofasystemicantibiotic prevented the occurrence of toxic shock syndrome (TSS). [12] 78% of patients received antibiotic prophylaxis while the remaining 22% received antibiotic treatment later if clinically indicated. 6% developed septicaemia of which 4% were from thegroupreceivingprophylaxisbuttherewerenocasesofTSS in either group. The results suggested that a single dose flucloxacillinprophylaxismayindeedhavearoleinprevention of TSS. [12] This study is specific and detailed in its clinical outcomes but lacks power to address the stated rare outcome effect. Alargeretrospectivecase-controlstudy(n=917)inBoston,USA aimed at preventing GAS infections by comparing routine infection surveillance data on burn patients cohorts admitted during two periods -1992-1994 and 1995-1997. [13] In total 543 and 435 children were admitted and studied, respectively. Thefirstcohortreceivedantibioticprophylaxiswhilethesecond cohort only received specific antibiotic treatment when sensitivitieswereknownafterscreeningcultures.Therewasno significant difference in patients developing GAS infections between both cohorts (P=0.71). It was concluded that routine antibiotic prophylaxis of burn wounds in children was not effective in reducing the incidence of GAS wound infection if children underwent both early excision of deep burns and screening cultures. [13] This study has a large paediatric populationbutsuffersfromtheretrospectivemethodologyand geographicalvariation. Mixedadultandpaediatricstudies Alargeprospectivecohortstudy(n=1213)inKuwaitstudiedthe efficacy of antibiotic prophylaxis against GAS infections by investigatingamixedagecohortofburnspatientsrangingfrom 15daysto93yearsold(mean=23years) over a5year period. [14] Overallonly14(1.1%)ofthe1213burnpatientsacquired streptococcal infections of which only one third were due to GAS.ThestudyconcludedthatthelowincidenceofGASinburns patients did not warrant penicillin prophylaxis in the first five post-burn days. [14] This study was adequately powered but suffers from short follow-up (5 days), poor level of evidence, selectionbiasanduncorrectedconfoundingfactorssuchasage, socioeconomic status, topical antibiotic use and no uniform systemicantibioticuse..An RCT (n=249) in Ohio, USA compared the effectiveness of prophylactic cephalothin (n=127, mean age 10.5+/-0.4 years) versus placebo (n=122, mean age 10.8+/-0.4 years) with operations using skin grafts for reconstruction following burns injury over a period of 25 months. [15] Prophylaxis was effective in reducing infection (0.8% versus 5.7%, p<0.03), reducing graft loss (99.89% versus 84.75%, p<0.02) and shorteninghospitalstay(12.38daysversus13.66days,p=0.02). This study concluded that antibiotic prophylaxis does reduce infectionratesingraftoperations.However,thisisanoldstudy (published in 1982) which does not address the issue of antibioticprophylaxisforburnwoundsatfirstpresentationand doesnotdiscusstheearlyburnssepsisnormallyexperiencedby burns victims. Also, this is a developed nation study and includes confounding factors e.g. different burn wound thickness,differentgraftsizeandthickness. A prospective cohort study (n=294) from Yale, USA compared wound infection rates in outpatient burns patients (ranging from 2 to >60 years old) treated with prophylactic systemic antibiotics in the emergency department (n=133) against patients with similar burns but received no prophylaxis (n=161). There was no significant difference in the infection ratesbetweenthetreatedanduntreatedpatients(3.8%versus 3.1%, p>0.75). [16] The authors agreed that prophylactic systemicantibioticsdidnotreducetheriskofwoundinfections. As this is an old (1985) observational cohort study focused on outpatient treatment with a 46% patient loss to follow up and poor epidemiological evidence, it can be argued that the study needsbettermethodologytobeconvincing. A retrospective cohort study (n=269) from the UK reviewed cohortsofburnspatientsoveraperiodof4years (1979) (1980) (1981) (1982) where prior systemic prophylaxis (erythromycin) was stopped and Streptococcus pyogenes infections were monitored. It was recorded that 9 patients (3.3%) were found to have Streptococcus pyogenes infections and all recovered after appropriate antibiotic treatments were given. It was further argued that since the actual infection rates were very low, targeteduseofsystemicprophylaxistohigh-riskburnspatients wouldbemorebeneficialthanblanketprophylaxiswhichwould increase bacterial resistance and economical burden while causing more antibiotic-related side effects. [17] This cohort study may not be relevant to current developing countries and lacksgoodmethodologyasithasnomatchingcontrolgroup,no statistical significance comparison, no follow-ups and has no epidemiologicaldata.
DISCUSSION
Systemic prophylactic antibiotics in burns patients have traditionally been used in four clinical settings: (i) early administration of anti-streptococcal drugs to prevent burn wound cellulitis, (ii) oral and enteral administration of antibiotics to prevent bacterial infection, (iii) peri-operative administration of antibiotics, and (iv) administration of broadspectrum antibiotics pending return of culture information in febrileorhypotensivepatients. [18] The available data from adult [8, 10] , paediatric [11, 12] and mixed population [14] [15] [16] [17] studies have demonstrated that systemicantibioticprophylaxisinburnspatientshavenorolein the prevention of bacterial infections. Moreover, GAS infection in burns patients is infrequent and is not further reduced by prophylactic antibiotics, providing those who had GAS on admission or subsequent surveillance cultures were treated appropriately. [13] Furthermore, peri-operative antibiotic prophylaxisdidnotdecreasetheincidenceofgraftordonorsite infection. [9] Children with significant burns often have moderate fever in the absence of infection [19] and in this circumstance, administration of broad-spectrum antibiotics is not appropriate and moreover injudicious use of broadspectrum antibiotics will increase bacterial resistance and may ultimately worsen outcomes in previously uninfected children. [18] The available data do not indicate that judicious use of antibiotics in febrile paediatric victims is incorrect. In established burns wound sepsis, targeted antibiotic usage may behelpfultoeradicatethebacteraemia/septicaemiaandreduce mortalityrates. [18] The role of early debridement and/or skin grafting cannot be underestimatedinthemanagementofpaediatricburns.AnRCT (n=344)comparedsurvivalratesofburnsvictimswhoreceived either early excision or topical antimicrobial therapy with skin grafting after spontaneous eschar separation. Mortality from burnswithoutinhalationinjurywasdecreasedbyearlyexcision from45%to9%inpatientswhowere17to30yearsofage(P< .025). [20] Aretrospectivestudyin1988(n=1674)investigated the mortality of children with burn injuries and found that mortalitywas substantiallyreducedthrough the useofprompt escharexcision. [21] Thesestudiesdemonstratethebenefitsin survival and length of hospital stay that can be achieved with thepracticeofearlyexcisioninpaediatricburns. [20, 21] There has also been a paucity of evidence on the relevance of post-operative antibiotics use in the management of paediatric burns patients and with the lack of support of the role of prophylacticantibioticinthesurgicalmanagementofpaediatric burnspatients [15] [16] [17] [18] [19] [20] ,thereseemstobeadiminishingroleof peri-operativeantibioticuse. However, it has been difficult to compare data from developed and developing countries due to geographical variation, complications in extrapolating adult data into paediatric population and challenging to draw conclusions due to variations in drug choices/doses/duration in all the studies included. Also, the presence of other confounding factors includingdifferinguniversalprecautions [19] ,otherconcurrent illnesses, variations in nutritional and hydration status, availability of resources and inconsistent practice in individual hospitals [22] addtothecomplexityofthesituation.Thereisa paucity of high quality evidence for systemic antibiotic prophylaxis for the management of paediatric burns in the developingworldthatneedstobeaddressed.
SUMMARY
The available evidence does not support the role of systemic antibiotic prophylaxis in the management of paediatric burns. This review also highlights a lack of a comprehensive evidence to address the pressing issue of whether prophylactic systemic antibiotics should be used in the management of burns in children. Withthepresentbodyofevidence,furtherstudiesofestablished and novel topical antimicrobial agents (other than topical antibiotics) are warranted to reduce colonisation and infection rates. While the limited available evidence do not support prophylactic systemic antibiotics in burn management, further adequately powered RCTs in developing countries may be warrantedtoaddressthisissuedefinitively.
